Holen Sie sich die Stockscreener-App
18.57
0.64%
-0.16
Handel nachbörslich:
18.57
Schlusskurs vom Vortag:
$18.73
Offen:
$18.6
24-Stunden-Volumen:
242.67K
Relative Volume:
0.76
Marktkapitalisierung:
$640.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-5.29%
1M Leistung:
+10.71%
6M Leistung:
-28.09%
1J Leistung:
+0.00%
1-Tages-Spanne:
$18.30
$18.84
1-Wochen-Bereich:
$18.30
$19.69
52-Wochen-Spanne:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
Firmenname
Ceribell Inc
Sektor
Branche
Telefon
(800) 436-0826
Adresse
360 N. PASTORIA AVENUE, SUNNYVALE
Vergleichen Sie CBLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
18.57 | 640.45M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
136.25 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.80 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.83 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.74 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.20 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-11-05 | Eingeleitet | BofA Securities | Buy |
| 2024-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
CeriBell, Inc. (NASDAQ:CBLL) Given Average Rating of “Buy” by Brokerages - Defense World
Ceribell, Inc. Announces Results of Annual Meeting - MSN
CeriBell: An EEG Concern Posting Impressive Growth (NASDAQ:CBLL) - Seeking Alpha
Ceribell shareholders approve board nominees and auditor By Investing.com - Investing.com South Africa
Ceribell shareholders approve board nominees and auditor - Investing.com
Bank of America Corp DE Invests $498,000 in CeriBell (NASDAQ:CBLL) - Defense World
Nuveen Asset Management LLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell CEO Chao Xingjuan sells $425,000 in stock By Investing.com - Investing.com Nigeria
Ceribell CEO Chao Xingjuan sells $425,000 in stock - Investing.com
Ameriprise Financial Inc. Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
BNP Paribas Financial Markets Invests $43,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc.: Strategic Growth and Profitability Amidst Market Challenges - TipRanks
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys Shares of 6,957 CeriBell (NASDAQ:CBLL) - Defense World
The medtech IPO window is finally open. Or is it? - MedTech Dive
CeriBell (NASDAQ:CBLL) Receives $32.50 Average Price Target from Brokerages - Defense World
Northern Trust Corp Invests $2.66 Million in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc.: Strong Q1 Performance and Promising Growth Justify Buy Rating - TipRanks
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference - GlobeNewswire
Ceribell CEO Chao Xingjuan sells $424,000 in stock - Investing.com Australia
Ceribell CEO Chao Xingjuan sells $424,000 in stock By Investing.com - Investing.com South Africa
Tower Research Capital LLC TRC Takes $37,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell stock holds $36 target amid US-China trade deal hopes - Investing.com Canada
Ceribell stock holds $36 target amid US-China trade deal hopes By Investing.com - Investing.com South Africa
US$30.75: That's What Analysts Think CeriBell, Inc. (NASDAQ:CBLL) Is Worth After Its Latest Results - Yahoo Finance
Wells Fargo & Company MN Takes $167,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Earnings Call Highlights Growth and Challenges - TipRanks
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - The Globe and Mail
AI in Clinics and Hospitals, Along with FDA Steps Signal Opportunity for Early Mover Advantages - The Globe and Mail
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% - Investing.com Nigeria
Ceribell, Inc.: A Strong Buy Amidst Promising Growth and Robust Fundamentals - TipRanks
CeriBell revenue jumps 42% to USD 20.5 million in Q1 2025 - Medical Buyer
MetLife Investment Management LLC Acquires Shares of 7,749 CeriBell (NASDAQ:CBLL) - Defense World
Barclays PLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Reports Strong Q1 2025 Growth - TipRanks
Ceribell, Inc. Receives Buy Rating Amid Strong Revenue Growth and Financial Performance - TipRanks
CeriBell Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% By Investing.com - Investing.com South Africa
Ceribell reports Q1 EPS (36c), consensus (46c) - TipRanks
Ceribell Reports First Quarter 2025 Financial Results - GlobeNewswire
CeriBell Inc expected to post a loss of 42 cents a shareEarnings Preview - TradingView
Invesco Ltd. Takes $252,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Finanzdaten der Ceribell Inc-Aktie (CBLL)
Es liegen keine Finanzdaten für Ceribell Inc (CBLL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Ceribell Inc-Aktie (CBLL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ROBERTSON REBECCA B | Director |
Jun 17 '25 |
Sale |
17.63 |
7,445 |
131,255 |
21,230 |
4.52%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):